vitronectin coated 48 well plate Search Results


vitronectin coated flasks  (Corning Life Sciences)
90
Corning Life Sciences vitronectin coated flasks
Vitronectin Coated Flasks, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/vitronectin+coated+12+well+plates/pmc08284774-56-25-26
Average 90 stars, based on 1 article reviews
vitronectin coated flasks - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
vitronectin-coated 96-well plates  (Cytomatrix Pty Ltd)
90
Cytomatrix Pty Ltd vitronectin-coated 96-well plates
Vitronectin Coated 96 Well Plates, supplied by Cytomatrix Pty Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/vitronectin+coated+96+well+plates/pmc06495722-111-7-10
Average 90 stars, based on 1 article reviews
vitronectin-coated 96-well plates - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
96-well plates coated with 500 ng human vitronectin  (Promega)
90
Promega 96-well plates coated with 500 ng human vitronectin
96 Well Plates Coated With 500 Ng Human Vitronectin, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/96+well+plates+coated+with+500+ng+human+vitronectin/pm11437656-196-15-17
Average 90 stars, based on 1 article reviews
96-well plates coated with 500 ng human vitronectin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
24-well tissue culture plates uncoated/coated with vitronectin (vn)  (Corning Life Sciences)
90
Corning Life Sciences 24-well tissue culture plates uncoated/coated with vitronectin (vn)
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
24 Well Tissue Culture Plates Uncoated/Coated With Vitronectin (Vn), supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/24+well+tissue+culture+plates+uncoated+coated+with+vitronectin++vn+/pmc06639931-75-12-14
Average 90 stars, based on 1 article reviews
24-well tissue culture plates uncoated/coated with vitronectin (vn) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
6-well culture plate coated with vitronectin xftm  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc 6-well culture plate coated with vitronectin xftm
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
6 Well Culture Plate Coated With Vitronectin Xftm, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/6+well+culture+plate+coated+with+vitronectin+xftm/pmc08129508-50-13-15
Average 90 stars, based on 1 article reviews
6-well culture plate coated with vitronectin xftm - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
6-well plates coated with vitronectin in celladhere buffer  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc 6-well plates coated with vitronectin in celladhere buffer
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
6 Well Plates Coated With Vitronectin In Celladhere Buffer, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/6+well+plates+coated+with+vitronectin+in+celladhere+buffer/pmc08531667-59-11-12
Average 90 stars, based on 1 article reviews
6-well plates coated with vitronectin in celladhere buffer - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
24-well plates coated with vitronectin 07180  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc 24-well plates coated with vitronectin 07180
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
24 Well Plates Coated With Vitronectin 07180, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/24+well+plates+coated+with+vitronectin+07180/pmc09379358-129-5-7
Average 90 stars, based on 1 article reviews
24-well plates coated with vitronectin 07180 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
vitronectin-coated 6-well plates  (Becton Dickinson)
90
Becton Dickinson vitronectin-coated 6-well plates
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
Vitronectin Coated 6 Well Plates, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/vitronectin+coated+6+well+plates/pm36521659-170-15-17
Average 90 stars, based on 1 article reviews
vitronectin-coated 6-well plates - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
96-well elisa plates coated with vitronectin  (Promega)
90
Promega 96-well elisa plates coated with vitronectin
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
96 Well Elisa Plates Coated With Vitronectin, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/96+well+elisa+plates+coated+with+vitronectin/10__1161_slash_circresaha__108__178434-219-14-32
Average 90 stars, based on 1 article reviews
96-well elisa plates coated with vitronectin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
vitronectin-coated 96-well plate  (STEMCELL Technologies Inc)
90
STEMCELL Technologies Inc vitronectin-coated 96-well plate
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
Vitronectin Coated 96 Well Plate, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/vitronectin+coated+96+well+plate/pm35472001-319-13-20
Average 90 stars, based on 1 article reviews
vitronectin-coated 96-well plate - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
vitronectin-coated 24-well plates  (Becton Dickinson)
90
Becton Dickinson vitronectin-coated 24-well plates
DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of <t>vitronectin</t> (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )
Vitronectin Coated 24 Well Plates, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/vitronectin+coated+48+well+plate/vitronectin+coated+24+well+plates/pm23207252-67-4-11
Average 90 stars, based on 1 article reviews
vitronectin-coated 24-well plates - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of vitronectin (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation

doi: 10.1186/s13046-019-1317-6

Figure Lengend Snippet: DU145 cells adhesion, invasion and intracellular activated pathways upon exposure to LO145 or LOR80. a DU145 adhesion, expressed as % of adherent cells, upon exposure to LO145 or LOR80 vs vehicle (considered as 100% control) and evaluated both in absence or presence of vitronectin (VN) for either 30 or 60 min. Stat. significances are expressed on vehicle. b DU145 adhesion measured as above, on VN after 60′ of exposure to LO145 or LOR80, untreated or pre-treated for 45′ RT with anti-αV-integrin monoclonal blocking antibody (anti-αV Ab) and indicated as LO145 αv and LOR80 αv , respectively; as negative control cells were treated by the anti-αV Ab alone. (LO145 αv / LO145)**; (LOR80 αv / LOR80)***; (LOR80/ vehicle) ***. c Western blotting analysis of pFAK, FAK, pAKT, AKT and γ-tubulin on cell lysates from DU145 untreated (CTR), or treated with LO145 or LOR80, alone or pre-exposed to anti-αV Ab (see above). pFAK and pAKT quantification is also reported. d Adhesion of DU145 measured as above, untreated (considered as 100%) or pretreated with the AKT inhibitor GDC-0068 for 16 h, were exposed to vehicle, LO145 or LOR80. (GDC-0068/ vehicle)***; (LOR80/ vehicle) **; (GDC-0068+ LOR80/ LOR80)* ( e ) DU145 invasion, expressed as % of invading cells, upon 16 h exposure to LOR80 treated with anti-αV Ab (LOR80 av ) or control Ab (LOR80 CTR Ab ) vs vehicle (considered as 100% control); as negative control cells were treated by CTR Ab alone (anti-pAKT antibody ineffective on non-permeabilized intact cells); (LOR80/ vehicle)***; (LOR80 CTR Ab / vehicle)***; (LOR80 av / LOR80)** ( f ) Invasion of DU145 measured as above, untreated (considered as 100%), or pretreated with the AKT inhibitor GDC-0068 for 6 h and exposed to vehicle, LO145 or LOR80;(GDC-0068/ vehicle)***; (LOR80/ vehicle)***; (GDC-0068 + LOR80/ LOR80)***. Results are representative of a single experiment and several experiments yielded similar results ( b ), or are the average of at least two experiments ( a ; d ; e ; f )

Article Snippet: Cell adhesion assays were performed using 24-well tissue culture plates uncoated/coated with vitronectin (VN) (Corning, NY 14831 USA).

Techniques: Control, Blocking Assay, Negative Control, Western Blot